Related Experiment Video

Updated: Jan 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K

Nanovaccines in gastrointestinal cancers

YuHan Wang1, Peng Huang2, Chun Li1

  • 1Department of General Surgery, Zigong Fourth People's Hospital, Zigong, Sichuan, China.

Frontiers in Immunology
|December 31, 2025
PubMed

Insights

Nanovaccines show promise for treating gastrointestinal (GI) cancers by delivering tumor antigens and adjuvants to activate immune responses. Further research is needed to overcome challenges in antigen delivery, safety, and regulatory approval for clinical use.

Area of Science:

  • Oncology
  • Immunology
  • Nanotechnology

Background:

  • Gastrointestinal (GI) cancers are a major global health concern.
  • Therapeutic tumor vaccines offer a promising approach for cancer treatment.
  • Nanotechnology integration, via nanovaccines, is emerging as a novel strategy for GI cancer immunotherapy.

Purpose of the Study:

  • To review advancements in nanovaccine design and application for GI cancers.
  • To elucidate the mechanisms of nanovaccine-mediated antigen and adjuvant delivery.
  • To highlight challenges and future directions for nanovaccine clinical translation.

Main Methods:

  • Review of current literature on nanovaccines in GI cancer immunotherapy.
  • Analysis of nanovaccine mechanisms for immune response activation.
  • Identification of challenges in antigen delivery, safety, and regulatory pathways.

Main Results:

  • Nanovaccines effectively deliver tumor-specific antigens and immunostimulatory adjuvants.
  • These nanovaccines activate robust immune responses crucial for cancer treatment.
  • Key challenges include optimizing antigen delivery, ensuring safety, and navigating regulatory hurdles.

Conclusions:

  • Nanovaccines hold significant potential to revolutionize GI cancer treatment paradigms.
  • Addressing challenges in delivery, safety, and regulation is critical for clinical translation.
  • Collaborative efforts are essential to accelerate the development and adoption of nanovaccines.
Keywords:
gastrointestinal cancersimmunotherapynanomedicineprecision medicinevaccine

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.4K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.2K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K